Le Lézard
Classified in: Health
Subjects: MAV, PSF, CPG, CMG, CFG

Media Advisory - Governments of Canada and Ontario, along with City of Toronto, to announce major investment


TORONTO, March 30, 2021 /CNW/ - The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, together with the Honourable Patty Hajdu, Minister of Health; the Honourable Doug Ford, Premier of Ontario; the Honourable Victor Fedeli, Ontario Minister of Minister of Economic Development, Job Creation and Trade; and His Worship, John Tory, Mayor of Toronto, will announce a significant investment to support Canada's future pandemic preparedness.

A media availability by teleconference will follow the announcement.

Date:

Wednesday, March 31, 2021



Time:

10:00 a.m. (ET)



Location:

1755 Steeles Avenue West


North York, Ontario

Note to media:

In order to ensure compliance with local public health guidance, only one camera person and one photographer will be authorized on site. As such, media outlets are invited to set up a camera and photography pool.

Media outlets are asked to confirm their virtual participation by contacting ISED Media Relations at [email protected] no later than 8:00 a.m. (ET) on Wednesday, March 31, 2021.

The event will be live-streamed on Innovation, Science and Economic Development Canada's Facebook page: Canadian Innovation.

In-person attendees will be required to wear a face covering at all times and to remain at least two metres apart from each other.

Stay connected

Find more services and information at Canada.ca/ISED.

Follow Innovation, Science and Economic Development Canada on social media.
Twitter: @ISED_CA, Facebook: CanadianInnovation, Instagram: @CDNinnovation and LinkedIn

SOURCE Innovation, Science and Economic Development Canada


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: